Christopher Wu
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Rheumatology top 5%
- Osteoarthritis Treatment and Mechanisms
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
Papers in
-
- RNA Research and Splicing 2
- Circular RNAs in diseases 2
-
- Osteoarthritis Treatment and Mechanisms 6
- Rheumatoid Arthritis Research and Therapies 3
- Co-authors
- Kenneth Kalunian (7 shared papers)Joseph J.�Y. Sung (4 shared papers)Jun Yu (4 shared papers)Simon S.M. Ng (3 shared papers)Yujuan Dong (3 shared papers)William Ka Kei Wu (1 shared paper)Zuhre Tutuncu (1 shared paper)Arthur Kavanaugh (1 shared paper)
- Journals
- Annals of Oncology (3 papers)British Journal of Cancer (2 papers)Clinics in Geriatric Medicine (1 paper)Nature Communications (1 paper)Expert Opinion on Drug Discovery (1 paper)
- Partner nations
- United StatesHong KongChina
In The Last Decade
Christopher Wu
22 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 93
- Cancer Research 374
- Rheumatology 286
- Immunology 168
- Molecular Biology 545
- Dermatology 61
Countries citing papers authored by Christopher Wu
This map shows the geographic impact of Christopher Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Wu more than expected).
Fields of papers citing papers by Christopher Wu
This network shows the impact of papers produced by Christopher Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Wu. The network helps show where Christopher Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 184 | |
| 2 | The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis. | 2007 | 135 |
| 3 | 2011 | 107 | |
| 4 | 2014 | 105 | |
| 5 | 2012 | 104 | |
| 6 | 2005 | 101 | |
| 7 | 2010 | 91 | |
| 8 | 2010 | 75 | |
| 9 | 2007 | 74 | |
| 10 | 2010 | 67 | |
| 11 | 2023 | 30 | |
| 12 | 2013 | 25 | |
| 13 | 2016 | 20 | |
| 14 | 2022 | 17 | |
| 15 | 2005 | 15 | |
| 16 | 2005 | 13 | |
| 17 | 2015 | 9 | |
| 18 | 2018 | 5 | |
| 19 | 2022 | 5 | |
| 20 | 2021 | 4 |
About Christopher Wu
Christopher Wu is a scholar working on Molecular Biology, Rheumatology, Oncology, Cancer Research and Immunology, having authored 24 papers that have together received 1.2k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (6 papers), Cancer-related molecular mechanisms research (4 papers), MicroRNA in disease regulation (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Colorectal Cancer Treatments and Studies (2 papers), RNA Research and Splicing (2 papers), Circular RNAs in diseases (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Cancer Research (374 citations), Rheumatology (286 citations), Immunology (168 citations), Molecular Biology (545 citations) and Dermatology (61 citations). Christopher Wu has collaborated with scholars based in United States, Hong Kong and China. Frequent co-authors include Kenneth Kalunian, Joseph J.�Y. Sung, Jun Yu, Simon S.M. Ng, Yujuan Dong, William Ka Kei Wu, Zuhre Tutuncu, Arthur Kavanaugh, Jeffry D Bieber and Phoebe Rich. Their work appears in journals such as Annals of Oncology, British Journal of Cancer, Clinics in Geriatric Medicine, Nature Communications and Expert Opinion on Drug Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.